Cargando…

Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures

Increasing studies have proved that malignant tumors are associated with energy metabolism. This study was aimed to explore biological variables that impact the prognosis of patients in the glycolysis-related subgroups of lung adenocarcinoma (LUAD). The mRNA expression profiling and mutation data in...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Chen, Zhang, Meng-Yu, Li, Rui, Liu, Ting-Ting, Li, Jian-Ping, Qu, Yi-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339438/
https://www.ncbi.nlm.nih.gov/pubmed/34368114
http://dx.doi.org/10.3389/fcell.2021.645482
_version_ 1783733601840398336
author Huo, Chen
Zhang, Meng-Yu
Li, Rui
Liu, Ting-Ting
Li, Jian-Ping
Qu, Yi-Qing
author_facet Huo, Chen
Zhang, Meng-Yu
Li, Rui
Liu, Ting-Ting
Li, Jian-Ping
Qu, Yi-Qing
author_sort Huo, Chen
collection PubMed
description Increasing studies have proved that malignant tumors are associated with energy metabolism. This study was aimed to explore biological variables that impact the prognosis of patients in the glycolysis-related subgroups of lung adenocarcinoma (LUAD). The mRNA expression profiling and mutation data in large LUAD samples were collected from the Cancer Genome Atlas (TCGA) database. Then, we identified the expression level and prognostic value of glycolysis-related genes, as well as the fractions of 22 immune cells in the tumor microenvironment. The differences between glycolysis activity, mutation, and immune infiltrates were discussed in these groups, respectively. Two hundred fifty-five glycolysis-related genes were identified from gene set enrichment analysis (GSEA), of which 43 genes had prognostic values (p < 0.05). Next, we constructed a glycolysis-related competing endogenous RNA (ceRNA) network which related to the survival of LUAD. Then, two subgroups of LUAD (clusters 1 and 2) were identified by applying unsupervised consensus clustering to 43 glycolysis-related genes. The survival analysis showed that the cluster 1 patients had a worse prognosis (p < 0.001), and upregulated differentially expressed genes (DEGs) are interestingly enriched in malignancy-related biological processes. The differences between the two subgroups are SPTA1, KEAP1, USH2A, and KRAS among top 10 mutated signatures, which may be the underlying mechanism of grouping. Combined high tumor mutational burden (TMB) with tumor subgroups preferably predicts the prognosis of LUAD patients. The CIBERSORT algorithm results revealed that low TMB samples were concerned with increased infiltration level of memory resting CD4+ T cell (p = 0.03), resting mast cells (p = 0.044), and neutrophils (p = 0.002) in cluster 1 and high TMB samples were concerned with increased infiltration level of memory B cells, plasma cells, CD4 memory-activated T cells, macrophages M1, and activated mast cells in cluster 2, while reduced infiltration of monocytes, resting dendritic cells, and resting mast cells was captured in cluster 2. In conclusion, significant different gene expression characteristics were pooled according to the two subgroups of LUAD. The combination of subgroups, TMB and tumor-infiltrating immune cell signature, might be a novel prognostic biomarker in LUAD.
format Online
Article
Text
id pubmed-8339438
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83394382021-08-06 Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures Huo, Chen Zhang, Meng-Yu Li, Rui Liu, Ting-Ting Li, Jian-Ping Qu, Yi-Qing Front Cell Dev Biol Cell and Developmental Biology Increasing studies have proved that malignant tumors are associated with energy metabolism. This study was aimed to explore biological variables that impact the prognosis of patients in the glycolysis-related subgroups of lung adenocarcinoma (LUAD). The mRNA expression profiling and mutation data in large LUAD samples were collected from the Cancer Genome Atlas (TCGA) database. Then, we identified the expression level and prognostic value of glycolysis-related genes, as well as the fractions of 22 immune cells in the tumor microenvironment. The differences between glycolysis activity, mutation, and immune infiltrates were discussed in these groups, respectively. Two hundred fifty-five glycolysis-related genes were identified from gene set enrichment analysis (GSEA), of which 43 genes had prognostic values (p < 0.05). Next, we constructed a glycolysis-related competing endogenous RNA (ceRNA) network which related to the survival of LUAD. Then, two subgroups of LUAD (clusters 1 and 2) were identified by applying unsupervised consensus clustering to 43 glycolysis-related genes. The survival analysis showed that the cluster 1 patients had a worse prognosis (p < 0.001), and upregulated differentially expressed genes (DEGs) are interestingly enriched in malignancy-related biological processes. The differences between the two subgroups are SPTA1, KEAP1, USH2A, and KRAS among top 10 mutated signatures, which may be the underlying mechanism of grouping. Combined high tumor mutational burden (TMB) with tumor subgroups preferably predicts the prognosis of LUAD patients. The CIBERSORT algorithm results revealed that low TMB samples were concerned with increased infiltration level of memory resting CD4+ T cell (p = 0.03), resting mast cells (p = 0.044), and neutrophils (p = 0.002) in cluster 1 and high TMB samples were concerned with increased infiltration level of memory B cells, plasma cells, CD4 memory-activated T cells, macrophages M1, and activated mast cells in cluster 2, while reduced infiltration of monocytes, resting dendritic cells, and resting mast cells was captured in cluster 2. In conclusion, significant different gene expression characteristics were pooled according to the two subgroups of LUAD. The combination of subgroups, TMB and tumor-infiltrating immune cell signature, might be a novel prognostic biomarker in LUAD. Frontiers Media S.A. 2021-07-22 /pmc/articles/PMC8339438/ /pubmed/34368114 http://dx.doi.org/10.3389/fcell.2021.645482 Text en Copyright © 2021 Huo, Zhang, Li, Liu, Li and Qu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Huo, Chen
Zhang, Meng-Yu
Li, Rui
Liu, Ting-Ting
Li, Jian-Ping
Qu, Yi-Qing
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
title Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
title_full Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
title_fullStr Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
title_full_unstemmed Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
title_short Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
title_sort glycolysis define two prognostic subgroups of lung adenocarcinoma with different mutation characteristics and immune infiltration signatures
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339438/
https://www.ncbi.nlm.nih.gov/pubmed/34368114
http://dx.doi.org/10.3389/fcell.2021.645482
work_keys_str_mv AT huochen glycolysisdefinetwoprognosticsubgroupsoflungadenocarcinomawithdifferentmutationcharacteristicsandimmuneinfiltrationsignatures
AT zhangmengyu glycolysisdefinetwoprognosticsubgroupsoflungadenocarcinomawithdifferentmutationcharacteristicsandimmuneinfiltrationsignatures
AT lirui glycolysisdefinetwoprognosticsubgroupsoflungadenocarcinomawithdifferentmutationcharacteristicsandimmuneinfiltrationsignatures
AT liutingting glycolysisdefinetwoprognosticsubgroupsoflungadenocarcinomawithdifferentmutationcharacteristicsandimmuneinfiltrationsignatures
AT lijianping glycolysisdefinetwoprognosticsubgroupsoflungadenocarcinomawithdifferentmutationcharacteristicsandimmuneinfiltrationsignatures
AT quyiqing glycolysisdefinetwoprognosticsubgroupsoflungadenocarcinomawithdifferentmutationcharacteristicsandimmuneinfiltrationsignatures